Ardent Health Faces Securities Fraud Lawsuit Over Collectability Issues

BFA Law Notifies Investors of March 9 Court Deadline to Join Class Action

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

Leading securities law firm Bleichmar Fonti & Auld LLP has filed a class action lawsuit against Ardent Health, Inc. (NYSE:ARDT) and certain of the Company's senior executives for securities fraud. The lawsuit alleges that Ardent Health misrepresented its receivables by delaying recognition of uncollectable accounts and misrepresenting its collection practices, leading to a significant stock drop in November 2025.

Why it matters

The lawsuit highlights concerns around Ardent Health's accounting practices and the potential impact on investors. It raises questions about the company's transparency and risk management, as well as the broader issue of accountability in the healthcare industry.

The details

According to the lawsuit, Ardent Health stated that it employed an active monitoring process to determine the collectability of its accounts receivable, but in reality, the company "utilized a 180-day cliff at which time an account became fully reserved." This allowed Ardent Health to report higher amounts of accounts receivable during the Class Period and delay recognizing losses on uncollectable accounts, which the lawsuit alleges is a violation of federal securities laws.

  • On November 12, 2025, after market hours, Ardent Health revealed it had completed 'hindsight evaluations of historical collection trends' that resulted in a $43 million decrease in revenue for the quarter.
  • Ardent Health also revealed that it increased its professional liability reserves by $54 million because of 'adverse prior period claim developments' resulting from a set of claims between 2019 and 2022 'as well as consideration of broader industry trends.'

The players

Ardent Health, Inc.

A company that operates acute care hospitals and other healthcare facilities.

Bleichmar Fonti & Auld LLP

A leading international law firm representing plaintiffs in securities class actions and shareholder litigation.

Got photos? Submit your photos here. ›

What’s next

Investors have until March 9, 2026, to ask the Court to be appointed to lead the case.

The takeaway

This case highlights the importance of transparency and accurate financial reporting in the healthcare industry, as well as the role of shareholder litigation in holding companies accountable for potential misconduct.